Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Perlecan Heparan Sulfate Proteoglycan Is a Critical Determinant of Angiogenesis in Response to Mouse Hind-Limb Ischemia

Qiang, Beiping ; Lim, Sang Yup ; Lekas, Michael ; Kuliszewski, Michael A. ; Wolff, Rafael ; Osherov, Azriel B. ; Rudenko, Dmitriy ; Leong-Poi, Howard ; Noyan, Hossein and Husain, Mansoor , et al. (2014) In Canadian Journal of Cardiology 30(11). p.1444-1451
Abstract


Background: Perlecan is a heparan sulfate proteoglycan (HSPG) constituent of the extracellular matrix with roles in cell growth, differentiation, and angiogenesis. The role of the HS side chains in regulating invivo angiogenesis after hind-limb ischemia is unknown. Methods: Heparan sulfate (HS)-deficient perlecan (Hspg2
δ3/δ3
) mice (n= 35), containing normal perlecan core protein but deficient in HS side chains, and wild-type (n= 33) littermates underwent surgical induction of hind-limb ischemia. Laser Doppler perfusion imaging (LDPI) and contrast-enhanced ultrasonography (CEU) provided serial assessment of hind-limb perfusion.... (More)


Background: Perlecan is a heparan sulfate proteoglycan (HSPG) constituent of the extracellular matrix with roles in cell growth, differentiation, and angiogenesis. The role of the HS side chains in regulating invivo angiogenesis after hind-limb ischemia is unknown. Methods: Heparan sulfate (HS)-deficient perlecan (Hspg2
δ3/δ3
) mice (n= 35), containing normal perlecan core protein but deficient in HS side chains, and wild-type (n= 33) littermates underwent surgical induction of hind-limb ischemia. Laser Doppler perfusion imaging (LDPI) and contrast-enhanced ultrasonography (CEU) provided serial assessment of hind-limb perfusion. Harvested muscles underwent immunostaining for endothelial cell density (CD31), real-time reverse transcription polymerase chain reaction RT-PCR for vascular endothelial growth factor (VEGF) mRNA expression and western blot analysis for VEGF and fibroblast growth factor (FGF)2 protein expression at days 2 and28. Results: Serial LDPI showed significantly greater perfusion recovery in ischemic limbs of wild-type compared with Hspg2
δ3/δ3
mice. CEU showed that normalized microvascular perfusion was increased in wild-type compared with Hspg2
δ3/δ3
mice at day 28 (0.67 ± 0.12 vs 0.26 ± 0.08; P= 0.001). CD31-positive cell counts were significantly higher in wild-type compared with Hspg2
δ3/δ3
mice on day 28 (122 ± 30 cells vs 84 ± 34 cells per high-power field [HPF]; P < 0.05). Endogenous VEGF mRNA expression (P < 0.05) and VEGF protein expression (P < 0.002) were significantly decreased in the ischemic limbs of Hspg2
δ3/δ3
mice compared with wild-type mice at day 2 and day 28, respectively. FGF2 protein expression showed no significant differences. Conclusions: These results suggest that the HS side chains in perlecan are important mediators of the angiogenic response to ischemia through a mechanism that involves upregulation of VEGF expression.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
publishing date
type
Contribution to journal
publication status
published
subject
in
Canadian Journal of Cardiology
volume
30
issue
11
pages
8 pages
publisher
Elsevier
external identifiers
  • pmid:25249499
  • scopus:84908478240
ISSN
0828-282X
DOI
10.1016/j.cjca.2014.06.003
language
English
LU publication?
no
id
d8712bc8-9907-4ae2-9fa3-33d27393ad9d
date added to LUP
2019-07-01 22:15:19
date last changed
2024-04-30 17:04:37
@article{d8712bc8-9907-4ae2-9fa3-33d27393ad9d,
  abstract     = {{<p><br>
                            Background: Perlecan is a heparan sulfate proteoglycan (HSPG) constituent of the extracellular matrix with roles in cell growth, differentiation, and angiogenesis. The role of the HS side chains in regulating invivo angiogenesis after hind-limb ischemia is unknown. Methods: Heparan sulfate (HS)-deficient perlecan (Hspg2<br>
                            <sup>δ3/δ3</sup><br>
                            ) mice (n= 35), containing normal perlecan core protein but deficient in HS side chains, and wild-type (n= 33) littermates underwent surgical induction of hind-limb ischemia. Laser Doppler perfusion imaging (LDPI) and contrast-enhanced ultrasonography (CEU) provided serial assessment of hind-limb perfusion. Harvested muscles underwent immunostaining for endothelial cell density (CD31), real-time reverse transcription polymerase chain reaction RT-PCR for vascular endothelial growth factor (VEGF) mRNA expression and western blot analysis for VEGF and fibroblast growth factor (FGF)2 protein expression at days 2 and28. Results: Serial LDPI showed significantly greater perfusion recovery in ischemic limbs of wild-type compared with Hspg2<br>
                            <sup>δ3/δ3</sup><br>
                             mice. CEU showed that normalized microvascular perfusion was increased in wild-type compared with Hspg2<br>
                            <sup>δ3/δ3</sup><br>
                             mice at day 28 (0.67 ± 0.12 vs 0.26 ± 0.08; P= 0.001). CD31-positive cell counts were significantly higher in wild-type compared with Hspg2<br>
                            <sup>δ3/δ3</sup><br>
                             mice on day 28 (122 ± 30 cells vs 84 ± 34 cells per high-power field [HPF]; P &lt; 0.05). Endogenous VEGF mRNA expression (P &lt; 0.05) and VEGF protein expression (P &lt; 0.002) were significantly decreased in the ischemic limbs of Hspg2<br>
                            <sup>δ3/δ3</sup><br>
                             mice compared with wild-type mice at day 2 and day 28, respectively. FGF2 protein expression showed no significant differences. Conclusions: These results suggest that the HS side chains in perlecan are important mediators of the angiogenic response to ischemia through a mechanism that involves upregulation of VEGF expression.<br>
                        </p>}},
  author       = {{Qiang, Beiping and Lim, Sang Yup and Lekas, Michael and Kuliszewski, Michael A. and Wolff, Rafael and Osherov, Azriel B. and Rudenko, Dmitriy and Leong-Poi, Howard and Noyan, Hossein and Husain, Mansoor and Tran, Kiet and Tryggvason, Karl and Hedin, Ulf and Tran-Lundmark, Karin and Strauss, Bradley H.}},
  issn         = {{0828-282X}},
  language     = {{eng}},
  month        = {{01}},
  number       = {{11}},
  pages        = {{1444--1451}},
  publisher    = {{Elsevier}},
  series       = {{Canadian Journal of Cardiology}},
  title        = {{Perlecan Heparan Sulfate Proteoglycan Is a Critical Determinant of Angiogenesis in Response to Mouse Hind-Limb Ischemia}},
  url          = {{http://dx.doi.org/10.1016/j.cjca.2014.06.003}},
  doi          = {{10.1016/j.cjca.2014.06.003}},
  volume       = {{30}},
  year         = {{2014}},
}